Clinical Study Risk Assessment

Similar documents
Adverse Event Reporting

1. INTRODUCTION 2. SCOPE 3. PROCESS

Document Title: Study Data SOP (CRFs and Source Data)

STH Researcher. Recording of research information in patient case notes

STANDARD OPERATING PROCEDURE SOP 325

Standard Operating Procedures (SOP) Research and Development Office

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Trial Management: Trial Master Files and Investigator Site Files

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

Standard Operating Procedure (SOP) Research and Development Office

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Research Staff Training

Standard Operating Procedures

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Auditing of Clinical Trials

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

STANDARD OPERATING PROCEDURE

Unofficial copy not valid

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Study Initiation Meeting

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Standard Operating Procedure Research Governance

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

STANDARD OPERATING PROCEDURE

Checklist prior to recruiting first patient

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Overview ICH GCP E6(R2) Integrated Addendum

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Document Title: Recruiting Process. Document Number: 011

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Title: Investigator Site File. Document Number: 019

Standard Operating Procedure (SOP) Research and Development Office

Keele Clinical Trials Unit

Standard Operating Procedure (SOP)

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

OFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

GCP Training for Research Staff. Document Number: 005

Document Title: File Notes. Document Number: 024

Investigator Site File Standard Operating Procedure (SOP)

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Document Title: Informed Consent for Research Studies

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

Good Clinical Practice: A Ground Level View

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Good Documentation Practices. Human Subject Research. for

STANDARD OPERATING PROCEDURE

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Corporate. Research Governance Policy. Document Control Summary

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Document Title: Training Records. Document Number: SOP 004

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

STANDARD OPERATING PROCEDURE SOP 205

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

STANDARD OPERATING PROCEDURE

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Safety Reporting in Clinical Research Policy Final Version 4.0

VCU Clinical Research Quality Assurance Assessment

Monitoring Clinical Trials

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

STANDARD OPERATING PROCEDURE 24. Training Records

The GCP Perspective on Study Monitoring

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

Scottish Nursing Guild Nurse Agency 160 Dundee Street Edinburgh EH11 1DQ

Marie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

Standard Operating Procedure (SOP) Research and Development Office

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

STANDARD OPERATING PROCEDURE

Researchfish outcome reporting system. User Guide for Researchers

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

Computer Validation Initiative Committee Membership Requirements

Allied Healthcare (Scottish Borders) Housing Support Service Unit 3 Annfield Business Centre Teviot Crescent Hawick TD9 9RE

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Standard Operating Procedure:

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Why do we need an addendum to ICH E6?

Advanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016

Storage and Archiving of Research Documents SOP 6

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Transcription:

Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016

DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona Brearley Date edited All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 2 of 9

1. Introduction Research Governance guidelines now require risk assessment of all research studies to be conducted to ensure patient safety and data integrity. Inspectors from regulatory authorities, i.e. the Medicines for Healthcare Regulatory Authority (MHRA) can ask to review these risk assessments so it is important that they are in place for all studies. Most of the risks covered in the risk assessment form should have been defined and explained in the protocol and patient information sheet so it may be beneficial for Investigators to complete the risk assessment form whilst drafting the protocol for a study to ensure that they cover all the relevant points. This may help to speed up the protocol approval process particularly in studies where MHRA approval is required. 2. Objectives To describe the procedure for the assessment of risk within clinical studies conducted within (as defined by the study being adopted by the SDRN) the Scottish Diabetes Research Network. The use of the forms provided will also ensure that risk assessment is carried out uniformly across SDRN sites in accordance with ICH-GCP guidelines. 3. Responsibility It is the responsibility of the local Principal Investigator to complete both the delegation of responsibilities log and the risk assessment, though it can be delegated to an experienced Research Nurse, if she/he is appropriately trained. The Principal Investigator should check and sign the list of tasks delegated to each team member as they have ultimate responsibility for the conduct of the study 4. General Points Download forms from the SOP area of www.sdrn.org.uk Use a black ball point pen Print all entries legibly Once the forms in Appendix A&B are completed, file in study master file. 5. Procedure After drafting the basic protocol for study, the Principal Investigator should complete the Clinical Study Risk Assessment Form (see Appendix A). Each box on the form should be completed and the form shown gives examples of factors to be considered in each part of the form. Many of these factors will included in the study protocol and/or the patient information sheet. If the protocol undergoes substantial changes once the risk assessment form has been completed, this form may require to be completed again. If the protocol has been written by the sponsor (i.e. a pharmaceutical company), then the local PI should carry out a risk assessment on the study before the final contract is signed. All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 3 of 9

Before the study begins, the Delegation of responsibilities log (see Appendix B) should be completed. This document should accurately reflect the tasks that each member of the study team conducts and constitutes part of the risk assessment process. The list of tasks given on the example is not exhaustive and can be adapted for each study simply adding extra tasks to the bottom of the list so that each task performed during the study can be accounted for. The Delegation of Responsibilities Log must be updated if members join or leave the study team so that it accurately reflects the study conduct throughout the course of that particular study. Both the Delegation of Responsibilities Log and the Clinical Study Risk Assessment Form should be filed in the study master file and must be archived at the end of the study for the appropriate time period. In the case of multicentre studies, the Delegation of Responsibilities Log will need to be completed for each individual site but the risk assessment should be the same for each site and should be completed centrally. However, each individual site will need a copy of the risk assessment form for the site file. All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 4 of 9

(APPENDIX A) All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 5 of 9

All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 6 of 9

All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 7 of 9

(APPENDIX B) All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 8 of 9

(APPENDIX C) All SDRN SOPs can now be downloaded from: http://www.sdrn.org.uk/?q=node/45 9 of 9